Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.
Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl MG, Leonardi CL, Mandelin AM, Menter MA, Merola JF, Pariser DM, Prussick RB, Ryan C, Shah KN, Weinberg JM, Williams MO, Wu JJ, Yamauchi PS, Van Voorhees AS. Armstrong AW, et al. Among authors: weinberg jm. J Am Acad Dermatol. 2017 Feb;76(2):290-298. doi: 10.1016/j.jaad.2016.10.017. Epub 2016 Nov 28. J Am Acad Dermatol. 2017. PMID: 27908543 Free article. Review.
From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis.
Choi YM, Debbaneh M, Weinberg JM, Yamauchi PS, Van Voorhees AS, Armstrong AW, Siegel M, Wu JJ. Choi YM, et al. Among authors: weinberg jm. J Am Acad Dermatol. 2016 Oct;75(4):798-805.e7. doi: 10.1016/j.jaad.2016.06.014. Epub 2016 Jul 25. J Am Acad Dermatol. 2016. PMID: 27461230 Review.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31887225 Free PMC article. Clinical Trial.
Treatments for psoriasis and the risk of malignancy.
Patel RV, Clark LN, Lebwohl M, Weinberg JM. Patel RV, et al. Among authors: weinberg jm. J Am Acad Dermatol. 2009 Jun;60(6):1001-17. doi: 10.1016/j.jaad.2008.12.031. Epub 2009 Apr 2. J Am Acad Dermatol. 2009. PMID: 19344980 Review.
Psoriasis: Embarking a dynamic shift in the skin microbiota.
Gupta M, Weinberg JM, Yamauchi PS, Patil A, Grabbe S, Goldust M. Gupta M, et al. Among authors: weinberg jm. J Cosmet Dermatol. 2022 Apr;21(4):1402-1406. doi: 10.1111/jocd.14273. Epub 2021 Jun 23. J Cosmet Dermatol. 2022. PMID: 34089221 Review.
Herpes zoster in psoriasis patients treated with tofacitinib.
Winthrop KL, Lebwohl M, Cohen AD, Weinberg JM, Tyring SK, Rottinghaus ST, Gupta P, Ito K, Tan H, Kaur M, Egeberg A, Mallbris L, Valdez H. Winthrop KL, et al. Among authors: weinberg jm. J Am Acad Dermatol. 2017 Aug;77(2):302-309. doi: 10.1016/j.jaad.2017.03.023. J Am Acad Dermatol. 2017. PMID: 28711084
437 results